Simulations Plus Inc. (NASDAQ:SLP), a leading provider of software for pharmaceutical discovery and development, reported its financial results for its 2011 fiscal year (FY11) and fourth quarter (4Q11) ended August 31, 2011. Consolidated revenues were $11.72 million, representing an increase of 9.4% over $10.71 million in FY10. Revenues for the pharmaceutical software and services sector were $8.74 million, representing an increase of 14.7% over $7.62 million in FY10. Consolidated net income was $2.71 million, representing an increase of 25.9% over $2.16 million in FY10. Revenues for the Words+ subsidiary were $2.98 million, a decrease of 3.6% over FY10. Net income per fully diluted share was $0.169, representing an increase of 29.3% over $0.131 for FY10. Cash increased to $10.18 million, representing an increase of 5.7% from $9.63 million at the end of FY10.
Simulations Plus, Inc. develops and produces software for use in pharmaceutical research and education, as well as provides contract research services to the pharmaceutical industry.
Read full article at : http://crwepicks.com/19135/top-news/slp-jakk-clno-pool-stock-in-focus-by...
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer (http://crwepicks.com/disclaimer ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. ( read more at http://crwepicks.com/disclaimer ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings, Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings, Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings, Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings, Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services and 4,000,000 shares of 144 restricted stocks from the company for management fee through end of June for Cleantech Transit, Inc. (CLNO.OB).